Snakebite envenoming kills and disables hundreds of thousands each year in the rural tropics

The problem

Snakebite envenoming is a treatable medical emergency that still kills and maims at the scale of a major cancer, almost entirely among people the global health system overlooks. A specific therapy — antivenom — has existed since the 1890s, yet the global system built around it fails on multiple fronts at once, and the death and disability toll has stayed high.

Observable evidence

• Roughly 1.8–2.7 million envenomings a year cause an estimated 81,410–137,880 deaths (Roberts et al., Nat Commun 2022; WHO snakebite fact sheets).
• Three to four times as many survivors are left with amputations, disfigurement, chronic kidney damage, blindness or contractures — on the order of 300,000–400,000 people a year.
• The world produces less than half the antivenom it needs, and in some regions much of the available product is ineffective or inappropriate for the local snakes (Wellcome, 2019).
• Snakebite was re-designated a WHO priority Neglected Tropical Disease in 2017; the 2019 WHO road map targets a 50% reduction in deaths and disability by 2030.

Who is affected

Victims are concentrated in farming and herding communities in tropical Asia, sub-Saharan Africa and Latin America. India alone accounts for roughly half of global snakebite deaths (~58,000/year); South Asia for ~70%. Children deteriorate fastest because they receive a higher venom dose per kilogram of body mass.

Scope

This is the top-level problem statement. Progress is constrained not by a single missing invention but by interacting failures that are scientific (products are species- and region-specific and hard to make broad), economic (effective products are unaffordable and commercially unviable for the poor), and logistical (cold chain, distance and delay). Those facets are addressed as distinct sub-issues so that a single solution can target each one.

Current state vs. desired state

Today a treatable condition routinely kills within hours because no safe, effective, affordable dose reaches the patient in time. The desired state is that any envenomed person in an endemic area can reach an effective, affordable treatment quickly enough to prevent death or permanent disability.

References

• WHO, Snakebite envenoming fact sheets and 2019 global strategy
• Roberts et al., "Global mortality of snakebite envenoming 1990–2019," Nat Commun (2022)
• Wellcome, "Snakebites — it's time to solve the world's biggest hidden health crisis" (2019)